Trial intelligence / Profile preview

Glimepiride Add-on to Metformin and Basal Insulin in Type 2 Diabetes

NCT02026310Completed

Start
Jan 2014
Primary completion
Nov 2015
Modality
Orthosteric Ligands
Countries
1
01

Overview

Randomised, open-label trial of glimepiride in type 2 diabetes mellitus (T2DM). Started Jan 2014; status: completed.

02

Drugs

glimepiride
03

Conditions

type 2 diabetes mellitus (T2DM)

Beyond the preview

Go deeper on NCT02026310.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02026310.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call